Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: Wes Stevens who wrote (17976)	7/24/1999 2:11:00 PM
From: LTK007	Read Replies (1) \| Respond to of 56535

Wes I am trying hard to find a reason why this news does NOT show that C-225 FDA approval is in the bag as such I am going to take 1/3 my previos position in IMCL,just to be sure I have something in it. <<kvaervner deal specifics by: max90 (7/M/Hollywood) 2246 of 2246 Article 5 of 47 Kvaerner awarded ImClone contract 07/09/1999 Chemical Business NewsBase: The Chemical Engineer Page 10 Copyright (C) 1999; Source: World Reporter (TM) Wouldn't this indicate C-225 approval is in the bag--a forgone conclusion << Kvaerner has won a $40 M contract to erect a biopharmaceutical plant for ImClone Systems at Branchburg, NJ. The plant will produce cancer drug C-225 monoclonal antibody, which is currently in Phase III. >>